Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions

被引：0
|
作者：
Mehilli, Julinda
Ndrepepa, Gjin
Kastrati, Adnan
Neumann, Franz-Josef
ten Berg, Jurrin
Bruskina, Olga
Dotzer, Franz
Seyfarth, Melchior
Dirschinger, Josef
Pache, J. rgen
Berger, Peter B.
Schömig, Albert
机构：
[1] Deutsch Herzzentrum Munich, Munich, Germany
[2] Duke Clin Res Inst, Durham, NC USA
[3] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-8000 Munich, Germany
[4] St Antonius Hosp, Nieuwegein, Netherlands
[5] Herz Zentrum Bad Krozingen, Bad Krozingen, Germany
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：812 / 813
页数：2
相关论文
共 50 条
  • [21] ABC of antithrombotic therapy - Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions
    Connolly, DL
    Lip, GYH
    Chin, BSP
    BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7377): : 1404 - 1407
  • [22] Direct thrombin inhibitors for the treatment of acute coronary syndromes and during percutaneous coronary interventions
    Paoli, G
    Merlini, PA
    Ardissino, D
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (30) : 3919 - 3929
  • [23] Controversies in non-ST-elevation acute coronary syndromes and percutaneous coronary interventions
    Bhatt, Deepak L.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2010, 77 (02) : 101 - +
  • [24] Acute coronary syndromes: interventions
    Verheugt, FWA
    LANCET, 1999, 353 : SII16 - SII19
  • [25] Overview of glycoprotein IIb/IIIa clinical trials with abciximab and eptifibatide in acute coronary syndromes and percutaneous coronary intervention
    Teirstein, P
    JOURNAL OF INVASIVE CARDIOLOGY, 1999, 11 : 26C - 30C
  • [26] COMPARISON OF PERSISTENCE AND ADHERENCE BETWEEN PRASUGREL AND CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTIONS
    Bae, J. P.
    Zhu, B.
    McCollam, P. L.
    Ramaswamy, K.
    Johnston, J. A.
    Cohen, D. J.
    Effron, M. B.
    VALUE IN HEALTH, 2008, 11 (06) : A408 - A408
  • [27] Management of Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation in the Setting of Acute Coronary Syndromes or Percutaneous Coronary Interventions
    Capodanno, Davide
    Angiolillo, Dominick J.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (01) : 113 - 124
  • [28] Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary Syndromes
    Otsuka, Tatsuhiko
    Baer, Sarah
    Losdat, Sylvain
    Kavaliauskaite, Raminta
    Ueki, Yasushi
    Zanchin, Christian
    Lanz, Jonas
    Praz, Fabien
    Haener, Jonas
    Siontis, George C. M.
    Zanchin, Thomas
    Stortecky, Stefan
    Pilgrim, Thomas
    Windecker, Stephan
    Raeber, Lorenz
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (23):
  • [29] The effect of adiponectin on the results of coronary interventions in patients with acute coronary syndromes: Primary phenomenon or epiphenomena?
    Amasyali, Basri
    Kilic, Ayhan
    Journal of Cardiology, 2015, 65 (3-4) : 257 - 258
  • [30] Pharmacodynamics (PD) of clopidogrel in patients with acute coronary syndromes undergoing percutaneous interventions (PCI).
    Fuchs, I
    Frossard, M
    Laggner, A
    Spiel, A
    Wohlschläger, E
    Jilma, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P53 - P53
12345